Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass
Authors:
- Rolf C.G. HuetRHRolf C.G. Huet
- Augueste SturkASAugueste Sturk
- Leon EijsmanLELeon Eijsman
- Charles R.H. WildevuurCWCharles R.H. Wildevuur
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 58 (4) , 1036-1039
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Rapid recovery of platelet function after cardiopulmonary bypass [letter]Blood, 1993
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- Platelet protection by aprotinin in cardiopulmonary bypass: Electron microscopic studyThe Annals of Thoracic Surgery, 1992
- Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirementsThe Annals of Thoracic Surgery, 1990
- Aspirin, blood loss, and transfusionThe Annals of Thoracic Surgery, 1990
- A Critical Reappraisal of the Bleeding Time*Seminars in Thrombosis and Hemostasis, 1990
- In vitro bleeding test - a simple method for the detection of aspirin effects on platelet functionThrombosis Research, 1989
- Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.Circulation, 1988
- PLATELET PRESERVATION BY APROTININ DURING CARDIOPULMONARY BYPASSThe Lancet, 1988
- Preoperative Aspirin Ingestion Increases Operative Blood Loss after Coronary Artery Bypass GraftingThe Annals of Thoracic Surgery, 1988